Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells

Seyed Sadegh Eslami ^1,2 , Davod Jafari ^1,2 , Abbas Ghotaslou ³, Moein Amoupour ², Amir Asri Kojabad ³, Rasool Jafari ⁴, Navid Mousazadeh ⁵, Parastoo Tarighi ² * , Majid Sadeghizadeh ⁶ *

Cited by CrossRef: 1

1- Zhang Y, Wang Y, Qian H. Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. Front Immunol. 2024;15 [Crossref]

2- Wang S, Chen H, Guo Z, Benariba M, Li M, Feng N, Wang X, Zhang Y, Zhou N. Tetrahedral DNA Nanostructures as Multifunctional Drug-Delivery Vehicles for Treating Non-Small Cell Lung Cancer. ACS Appl Nano Mater. 2024;7(23):27071 [Crossref]

3- Jalilian E, Abolhasani-Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci Rep. 2023;13(1) [Crossref]

4- Ünlü İ, Özdemir İ, Öztürk Ş, Tuncer M. Effects of Curcumin and Doxorubicin on the Viability of Neuroblastoma Cancer Cell Line. J Cukurova Anesth Surg. 2024;7(3):191 [Crossref]